Back to team page
Andrew has 10 years of experience in the medical device industry in various roles within quality assurance and regulatory affairs. During this time, he led preparation efforts for a successful first-time FDA inspection, research efforts to support 510(k) submissions, and investigation and resolution of product and process deficiencies. He also implemented statistical methods and lean tools to improve process efficiency. This experience has provided him with a unique perspective on how a quality system can be an effective tool for any company. At Bold Insight, Andrew is responsible for the development and maintenance of our quality system, ensuring the continuous improvement of our processes and the quality of service we provide our clients. Andrew holds an BS in Bioengineering from Michigan State University.
Bold facts
Learn more about
Choose an experienced research partner to avoid privacy pitfalls that can derail successful data collection.
Read our team’s latest bold insights
Bold Insight launched a global AI study in March 2023 that included: 24 multilingual interviews conducted with UX researchers in 19 countries, spanning 22 languages. 27 interviews in English with global UX researchers representing 24 countries. Our global study led us...
Speech technology helps UX researchers bridge linguistic and cultural barriers. Effective use, however, depends on balancing the roles of humans and tech.
Generative AI can speed up repetitive research tasks, but it’s still hard to trust each output. Our global AI study measures the concrete impact.
China and the European Union are regulating AI ethics. The mandate for medtech design teams: build AI-powered products that meet ethics standards and inspire user trust.